Request Demo
Last update 29 Aug 2025
Guangzhou Pui's Pharmaceutical Factory Ltd.
Last update 29 Aug 2025
Overview
Related
CTR20252230
评估受试制剂格列齐特缓释片（规格：60 mg）与参比制剂（达美康®缓释片）（规格：60 mg）在健康成年参与者空腹和餐后状态下的单中心、开放、随机、单剂量、两周期、两序列、交叉生物等效性试验
[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study to evaluate the bioequivalence of the test preparation, gliclazide extended-release tablets (strength: 60 mg), and the reference preparation (Diamericon® extended-release tablets) (strength: 60 mg) in healthy adult participants in the fasting and fed state.
CTR20200159
健康中国籍志愿者在空腹和餐后状态下使用两种非诺贝特片（III）制剂的生物等效性研究
[Translation] Bioequivalence study of two fenofibrate tablets (III) in healthy Chinese volunteers in fasting and fed state
CTR20130123
格列齐特缓释胶囊治疗2型糖尿病双盲双模拟、阳性药平行对照多中心临床试验。
[Translation] A double-blind, double-dummy, positive drug parallel-controlled multicenter clinical trial of gliclazide sustained-release capsules in the treatment of type 2 diabetes.
100 Clinical Results associated with Guangzhou Pui's Pharmaceutical Factory Ltd.
Login to view more data
Login to view more data
100 Deals associated with Guangzhou Pui's Pharmaceutical Factory Ltd.
Login to view more data
100 Translational Medicine associated with Guangzhou Pui's Pharmaceutical Factory Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Feb 2026
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free